about
Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.Detection of alpha human papillomaviruses in archival formalin-fixed, paraffin-embedded (FFPE) tissue specimens.Commercially available molecular tests for human papillomaviruses (HPV): 2015 update.Betapapillomaviruses in the anal canal of HIV positive and HIV negative men who have sex with men.High HPV infection prevalence in men from infertile couples and lack of relationship between seminal HPV infection and sperm quality.Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.New Insights into the Evolutionary and Genomic Landscape of Molluscum Contagiosum Virus (MCV) based on Nine MCV1 and Six MCV2 Complete Genome SequencesA very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide studyClinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT FrameworkNovel Circo-Like Virus Detected in a Croatian Bat PopulationUsing the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assayAlinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening SettingsSequence ambiguity determined from routine pol sequencing is a reliable tool for real-time surveillance of HIV incidence trendsPrevalence of the Helicobacter pylori homA and homB genes and their correlation with histological parameters in childrenClinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 FrameworkValidation of EUROArray HPV test using the VALGENT frameworkEvaluation and optimization of the clinical accuracy of Hybribio's 14 High-risk HPV with 16/18 Genotyping assay within the VALGENT-3 frameworkA Preliminary Study of the Virome of the South American Free-Tailed Bats (Tadarida brasiliensis) and Identification of Two Novel Mammalian VirusesA novel reassortant mammalian orthoreovirus with a divergent S1 genome segment identified in a traveler with diarrhea
P50
Q31030676-EEA667E0-7F21-4C67-82E4-FD017E16937EQ38383802-EE8C019A-9175-4606-BC0E-A944E68B4BE7Q38646081-9EE36455-6D23-47E6-97E8-C99101744035Q42201697-274E574B-E011-4690-BAD3-1CCD157F2B31Q43469953-09FD86F8-0061-4B37-975E-C52360EC573DQ47097439-7F36E9C7-89D8-4DEC-9206-379F07AA6260Q58116493-ED6E49B8-E478-4BD9-88DF-874BD5D13C82Q58613690-36FD595E-B73B-4268-8FCA-A2CDE12CB3C6Q58749448-347BB1ED-37A6-47E6-A4F7-E6B66250C1DEQ64103233-F25C6757-680F-4D65-94AD-97648D6923FCQ90379226-4B1BDAE5-AB15-4D75-8B7B-6E7EA7E50123Q91011060-AB0258A5-9FBE-40FF-BECB-CF23F3848ECEQ91224235-974BAD89-BF0D-41DD-86A7-2D9E67D6CCAFQ91340623-221E0702-73AA-40B9-81B3-191B24F8F60BQ91410152-B80F6B36-F852-443E-BB84-F9A1F1E78190Q91485694-1F8151B6-DA14-433E-ADAB-7796B85823CCQ91553729-D9E267E6-9139-4208-AD03-5D3461DBF8AAQ91867959-76031589-8E25-4F2B-B8D9-75825248ECBAQ92600934-6139361E-F39A-423A-9231-08E3CD4A695D
P50
description
microbioloog uit Slovenië
@nl
researcher
@en
ricercatore
@it
taighdeoir
@ga
հետազոտող
@hy
name
M Poljak
@ast
M Poljak
@es
M Poljak
@nl
Mario Poljak
@de
Mario Poljak
@en
Mario Poljak
@ga
Mario Poljak
@sl
type
label
M Poljak
@ast
M Poljak
@es
M Poljak
@nl
Mario Poljak
@de
Mario Poljak
@en
Mario Poljak
@ga
Mario Poljak
@sl
altLabel
M Poljak
@en
prefLabel
M Poljak
@ast
M Poljak
@es
M Poljak
@nl
Mario Poljak
@de
Mario Poljak
@en
Mario Poljak
@ga
Mario Poljak
@sl
P214
P227
P106
P1280
P21
P214
P227
1054173354
P31
P496
0000-0002-3216-7564
P569
1965-01-01T00:00:00Z
P6556
P7859
viaf-315232519